Syphilis Staph aureus Clostridium Pneumonia Dipteria Staph aureus Clostridium Pneumonia Dipteria Microbiology from apurba sastry
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have thorough content from medical microbiology textbooks on all five topics. Let me compile a comprehensive, well-organized answer.
Microbiology - Key Organisms (Apurba Sastry Style)
Content sourced from Medical Microbiology 9e and Sherris & Ryan's Medical Microbiology, 8th Edition.
1. SYPHILIS (Treponema pallidum)
Organism
- Thin, motile spirochete; obligate human pathogen
- Cannot be grown on artificial culture media
- Corkscrew motility; binds fibronectin via adhesins
Transmission
- Sexual contact with active primary/secondary lesions (>50% transmission rate when lesion present)
- Transplacental (congenital syphilis) - throughout latency
- Needle sharing (IV drug users)
- Tertiary syphilis is NOT infectious
Pathogenesis
- Enters through microabrasions in mucosa → multiplies in subepithelium → minimal initial reaction (few outer membrane antigens)
- Stimulates endarteritis (endothelial swelling/proliferation of arterioles) → necrosis, ulceration
- Disseminates via blood → systemic manifestations
Clinical Stages
| Stage | Key Features |
|---|---|
| Primary | Painless indurated ulcer = Chancre (genitalia/cervix/anal/oral); regional painless lymphadenopathy; heals in 4-6 weeks; incubation ~3 weeks |
| Secondary | 2-8 weeks after chancre; symmetric maculopapular rash on trunk, extremities, palms, soles, face; generalized lymphadenopathy; fever, malaise; condylomata lata (warty perineal lesions); teeming with spirochetes; resolves spontaneously |
| Latent | No clinical signs; serologically positive; early latent (<4 yr) - relapses possible; late latent (>4 yr) - no relapses, resistant to reinfection; 1/3 never progress |
| Tertiary | ~15-20 years later (1/3 of untreated); neurosyphilis, cardiovascular syphilis, gummas |
Tertiary Syphilis - Details
- Neurosyphilis: Chronic meningitis, cortical degeneration (psychosis, dementia), tabes dorsalis (demyelination of posterior columns → ataxia, wide-based gait, loss of sensation), paresis (mnemonic: Personality, Affect, Reflexes, Eyes, Sensorium, Intellect, Speech)
- Cardiovascular syphilis: Aortitis → aortic aneurysm (ascending/transverse aorta), aortic valve incompetence
- Gummas: Localized granulomas in skin, bone, joints, viscera
Congenital Syphilis
- Fetus susceptible after 4th month of gestation
- Features: rhinitis ("snuffles"), rash, bone changes (saddle nose, saber tibia, Hutchinson's teeth)
Diagnosis
- Dark-field microscopy (primary/secondary lesions)
- Serology: Non-treponemal (VDRL, RPR) for screening; Treponemal (FTA-ABS, TPHA) for confirmation
- HIV co-infection: syphilitic lesions are a portal for HIV transmission
Treatment
- Benzathine penicillin G is drug of choice for all stages
- Neurosyphilis: IV aqueous penicillin G
2. STAPHYLOCOCCUS AUREUS
Key Trigger Words
Coagulase, cytotoxins, exfoliative toxins, enterotoxins, toxic shock syndrome toxin (TSST), MRSA
Biology & Virulence
- Gram-positive cocci in clusters (grape-like); catalase positive; coagulase positive
- Survives on dry surfaces for long periods (thick peptidoglycan, no outer membrane)
- Virulence factors: structural (protein A - binds IgG Fc region, avoids phagocytosis; capsule; biofilm) and toxins/enzymes
Key Toxins
| Toxin | Disease |
|---|---|
| Coagulase | Clots fibrinogen; hallmark of S. aureus |
| Exfoliative toxin (A & B) | Scalded Skin Syndrome (SSS) - serine proteases that cleave desmoglein-1 |
| Enterotoxins (A-G) | Food poisoning - heat stable, preformed toxin, rapid onset (1-6 hr) |
| TSST-1 | Toxic Shock Syndrome - superantigen, massive cytokine release |
| Panton-Valentine Leukocidin (PVL) | Tissue necrosis, destroys leukocytes; associated with MRSA |
| Alpha toxin | Cell membrane disruption; hemolysis |
Epidemiology
- Normal flora on skin and mucosal surfaces (nose - 30% of population are carriers)
- MRSA = now most common cause of community-acquired skin/soft-tissue infections
- Risk factors: foreign body (catheter, prosthesis), prior surgery, immunosuppression, antecedent viral respiratory infection
Diseases
- Toxin-mediated: Food poisoning, TSS, Scalded Skin Syndrome
- Pyogenic (localized): Impetigo, folliculitis, furuncles, carbuncles, wound infections
- Systemic: Bacteremia, endocarditis, osteomyelitis, septic arthritis, pneumonia, meningitis
Diagnosis
- Gram stain (gram-positive cocci in clusters)
- Mannitol-salt agar / Chromogenic agar (selective media)
- Coagulase test (tube coagulase = definitive)
- NAAT for MRSA screening
Treatment
- Localized: Incision & drainage
- Systemic: Empirical MRSA coverage
- Oral: TMP-SMX, doxycycline, clindamycin, linezolid
- IV: Vancomycin (DOC); alternatives: daptomycin, tigecycline, linezolid
- Food poisoning: Symptomatic only
3. CLOSTRIDIUM SPECIES
All are anaerobic, gram-positive, spore-forming rods
A. Clostridium difficile
Trigger Words: Spore former, antibiotic-associated diarrhea, pseudomembranous colitis, Toxin A & B
| Feature | Detail |
|---|---|
| Toxins | Toxin A (enterotoxin) - attracts neutrophils, stimulates cytokines; Toxin B (cytotoxin) - increases intestinal permeability → diarrhea |
| Pathogenesis | Antibiotics (clindamycin, cephalosporins, fluoroquinolones) suppress normal flora → C. diff overgrowth |
| Epidemiology | <5% carriage in healthy adults; spores resist decontamination |
| Disease | Antibiotic-associated diarrhea; Pseudomembranous colitis (profuse diarrhea, fever, whitish plaques on colonic mucosa) |
| Diagnosis | Detect cytotoxin/enterotoxin or toxin genes in feces (NOT culture alone) |
| Treatment | Discontinue offending antibiotic; metronidazole or vancomycin (oral) for severe disease; fecal transplant for recurrent disease |
| Note | Relapse common - antibiotics don't kill spores; second course usually required |
B. Clostridium perfringens
Trigger Words: Spore former, myonecrosis (gas gangrene), sepsis, food poisoning
| Feature | Detail |
|---|---|
| Biology | Large gram-positive rods; rapid growth; spores rarely visible |
| Toxins | Alpha toxin (lecithinase/phospholipase C) - main virulence factor; lysis of blood cells, tissue destruction, massive hemolysis; heat-sensitive enterotoxin (food poisoning) |
| Epidemiology | Ubiquitous (soil, water, intestines); Type A = most human infections |
| Diseases | Gas gangrene (myonecrosis) - surgical/traumatic wounds; Food poisoning - contaminated meat (beef, poultry, gravy) held at 5-60°C; Sepsis |
| Diagnosis | Large rectangular gram-positive rods on Gram stain; characteristic hemolytic colonies |
| Treatment | Severe: Surgical debridement + high-dose penicillin; food poisoning = symptomatic |
C. Clostridium tetani
Trigger Words: Spore former, neurotoxin, contaminated wound, tetanus, vaccine
| Feature | Detail |
|---|---|
| Toxin | Tetanospasmin (heat-labile neurotoxin) - blocks release of inhibitory neurotransmitters (GABA, glycine) → spastic paralysis |
| Spore | Drumstick/terminal spores; extremely oxygen-sensitive organism |
| Disease | Tetanus: trismus (lockjaw), risus sardonicus, opisthotonus, spastic paralysis; neonatal tetanus (umbilical stump infection) |
| Diagnosis | Clinical; culture very difficult (strict anaerobe) |
| Treatment | Wound debridement + penicillin/metronidazole + antitoxin (TIG) + tetanus toxoid vaccination |
| Prevention | 3 doses toxoid + booster every 10 years |
D. Clostridium botulinum
Trigger Words: Spore former, neurotoxin, flaccid paralysis, foodborne/infant botulism, NO vaccine
| Feature | Detail |
|---|---|
| Toxin | Botulinum toxin (types A, B most common; E, F also) - blocks release of acetylcholine at peripheral cholinergic synapses → flaccid paralysis |
| Contrast with Tetanus | Tetanus = spastic; Botulinum = flaccid |
| Diseases | Foodborne botulism (blurred vision, dry mouth, constipation, descending flaccid paralysis); Infant botulism (contaminated honey/soil); Wound botulism; Inhalation botulism |
| Spores | Found in soil worldwide; heat resistant |
| Toxin | Heat labile - destroyed by heating at 60-100°C for 10 min |
| Diagnosis | Toxin in food, serum, feces, or wound |
| Treatment | Penicillin/metronidazole + trivalent botulinum antitoxin + ventilatory support |
4. PNEUMONIA (Streptococcus pneumoniae - Pneumococcus)
Biology & Virulence
- Gram-positive lancet-shaped diplococci (pairs)
- Catalase negative, alpha-hemolytic on blood agar (green zone)
- Key virulence factor: Polysaccharide capsule (>90 serotypes; inhibits phagocytosis; anticapsular antibodies are protective)
- Other: pneumolysin, IgA protease, surface adhesins
Epidemiology
- Carried asymptomatically in nasopharynx (25-50% of children, less in adults)
- Spreads via respiratory droplets
- Peak incidence: winter/spring (cool months)
- At-risk groups: children <5 yr, elderly, asplenic/hyposplenic, hypogammaglobulinemia, HIV, chronic lung disease, alcoholism, DM, CHF
- WHO estimate: >750,000 children <5 yr die annually from pneumococcal pneumonia/meningitis
Pathogenesis
Oropharyngeal colonization → aspiration into lower airways → rapid multiplication in alveolar edema fluid → erythrocyte/neutrophil/macrophage accumulation → lobar consolidation → resolution when anticapsular antibodies form
Predisposing factors: antecedent viral illness (influenza), chronic pulmonary disease, alcoholism, CHF, diabetes, renal disease, splenectomy (unable to clear encapsulated organisms)
Clinical Diseases
- Lobar Pneumonia (most classic): Abrupt onset; severe shaking chill + sustained fever 39-41°C; productive cough with blood-tinged/rust-coloured sputum; pleuritic chest pain; consolidation in lower lobes; preceded by viral URTI 1-3 days prior
- Meningitis - most common bacterial meningitis in adults
- Otitis Media - most common cause in children
- Sinusitis
- Bacteremia
Diagnosis
- Gram stain of sputum: gram-positive lancet-shaped diplococci, with PMNs
- Culture on blood agar: alpha-hemolytic colonies; optochin sensitive (distinguishes from other streptococci); bile solubility positive
- Urinary antigen test (rapid, sensitive for adults)
- Blood cultures for bacteremia
Treatment
- Community-acquired pneumonia: Penicillin G or amoxicillin (if sensitive); macrolides/respiratory fluoroquinolones for atypicals or resistant strains
- Increasing penicillin resistance - ceftriaxone, levofloxacin, moxifloxacin
Prevention (Vaccines)
- PPSV23 (Pneumovax): 23-valent polysaccharide vaccine for adults ≥65 yr and high-risk groups
- PCV13/PCV20 (Prevnar): Conjugated vaccine for children and adults; broader protection including herd immunity
5. DIPHTHERIA (Corynebacterium diphtheriae)
Biology & Key Features
- Gram-positive rod with clubbed ends (palisade/Chinese-letter arrangement on stain)
- Non-motile, non-spore-forming
- Produces diphtheria exotoxin (if lysogenised by beta-phage carrying tox gene)
- Toxin regulated by DTxR (diphtheria toxin repressor) - represses toxin at high iron concentrations
Diphtheria Toxin - Mechanism
- A-B subunit toxin:
- B subunit: Binds host cell receptor (heparin-binding EGF precursor); facilitates entry
- A subunit: Catalytic; ADP-ribosylates and inactivates Elongation Factor-2 (EF-2) → terminates host cell protein synthesis completely
- One toxin molecule can inactivate ALL EF-2 in a cell
Epidemiology
- Worldwide distribution; poor urban areas with crowding, low vaccination
- Transmitted via respiratory droplets or skin contact
- Reservoir: asymptomatic carriers in oropharynx/skin of immune individuals
- Humans are the only reservoir
- Largely eliminated in vaccinated countries; risk with travel to endemic areas (Indian subcontinent, Africa, SE Asia)
- ~200,000 cases/yr in 1921 USA; only 2 cases since 2003
Clinical Diseases
Respiratory Diphtheria
- Incubation: 2-4 days
- Sudden onset: malaise, sore throat, exudative pharyngitis, low-grade fever
- Exudate evolves into thick grey pseudomembrane (bacteria + lymphocytes + fibrin + dead cells) over tonsils/pharynx/larynx
- Pseudomembrane bleeds on attempted removal
- Toxin disseminates via blood → systemic disease (myocarditis, neuropathy)
- Bull-neck appearance (cervical lymphadenopathy + soft tissue edema)
- Laryngeal diphtheria: Hoarseness, croupy cough, risk of airway obstruction
Systemic Complications (from toxin)
- Myocarditis (2nd-3rd week) - most common cause of death
- Neuropathy: Palatal palsy → nasal voice/regurgitation; oculomotor palsy; peripheral neuropathy
- Adrenal involvement
Cutaneous Diphtheria
- Chronic, non-healing ulcers; less systemic toxicity
- Can transmit organism
Diagnosis
- Gram stain: metachromatic granules (Babes-Ernst granules) with Albert's stain (bluish-green organisms, dark granules)
- Culture on Loeffler's serum slope (rapid growth) and Tellurite agar (black colonies - selective)
- Elek test: Double immunodiffusion to detect toxin production (in vitro toxigenicity test)
- PCR for tox gene
Treatment
- Diphtheria antitoxin (DAT) - given immediately (neutralizes free toxin; does NOT reverse fixed toxin)
- Penicillin or erythromycin - kills the organism, eliminates carrier state
- Supportive: airway management, cardiac monitoring
Prevention
- DPT/DTP vaccine: Diphtheria toxoid (inactivated toxin - formaldehyde treated)
- Primary series: 3 doses + boosters
- Tetanus + Diphtheria (Td) booster every 10 years
Quick Comparison Table
| Feature | Syphilis | S. aureus | C. difficile | S. pneumoniae | C. diphtheriae |
|---|---|---|---|---|---|
| Morphology | Spirochete | GP cocci clusters | GP rod (anaerobe) | GP diplococci | GP rod (clubs) |
| Key toxin/factor | None (immune-mediated) | Coagulase, TSST | Toxin A + B | Capsule | Diphtheria toxin (EF-2 inhibition) |
| Culture | Cannot be cultured | Blood agar | Anaerobic culture | Blood agar (optochin sensitive) | Loeffler's / Tellurite agar |
| Key disease | Chancre → rash → tertiary | Abscess, TSS, food poisoning | Pseudomembranous colitis | Lobar pneumonia | Pseudomembrane, myocarditis |
| Treatment | Benzathine penicillin G | Vancomycin (MRSA) | Metronidazole/Vancomycin | Penicillin/Ceftriaxone | Antitoxin + Penicillin |
| Vaccine | No | No | No | PCV13, PPSV23 | DTP (toxoid) |
Sources: Medical Microbiology 9e (Murray/Rosenthal), Sherris & Ryan's Medical Microbiology 8th Edition
This is a shared conversation. Sign in to Orris to start your own chat.